Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 7,923 | 316,815 | 9,393 | 5,847 | 3,604 |
| Gross Profit | 7,923 | 316,815 | 9,393 | 5,847 | 3,604 |
| Operating Expenses | 79,143 | 72,737 | 69,509 | 67,124 | 63,571 |
| Operating Income | -71,220 | 244,078 | -60,116 | -61,277 | -59,967 |
| Other Income | 1,179 | 1,630 | 1,944 | 2,598 | 3,069 |
| Pre-tax Income | -70,041 | 245,708 | -58,172 | -58,679 | -56,898 |
| Income Tax | N/A | 823 | 56 | 79 | -135 |
| Net Income Continuous | -70,041 | 244,885 | -58,228 | -58,758 | -56,763 |
| Net Income | $-70,041 | $244,885 | $-58,228 | $-58,758 | $-56,763 |
| EPS Basic Total Ops | -0.58 | 2.30 | -0.54 | -0.56 | -0.55 |
| EPS Basic Continuous Ops | -0.58 | 2.30 | -0.54 | -0.56 | -0.55 |
| EPS Diluted Total Ops | -0.58 | 2.28 | -0.54 | -0.56 | -0.55 |
| EPS Diluted Continuous Ops | -0.58 | 2.28 | -0.54 | -0.56 | -0.55 |
| EBITDA(a) | $-67,951 | $247,328 | $-58,009 | $-59,550 | $-58,465 |